Screener
CorMedix CRMD Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: CorMedix’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Total Other (Expense) Income | (8,013) | 519 |
| Income before income taxes | 55,645 | 20,644 |
| Tax expense | 17,044 | — |
| Net Income | $38,601 | $20,644 |
| Other Comprehensive Loss: | ||
| Unrealized loss from investments | (1) | (5) |
| Foreign currency translation loss | - | (1) |
| Total Other Comprehensive Loss | (1) | (6) |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's net income?
- CorMedix (CRMD) reported net income of $38.6M in Q1 2026.
- How has CorMedix's net income changed year-over-year?
- CorMedix's net income increased by 87.0% year-over-year, from $20.64M to $38.6M.
- What is the long-term trend for CorMedix's net income?
- Over 3 years (2021 to 2025), CorMedix's net income has grown at a 79.5% compound annual growth rate (CAGR), from -$28.21M to $163.06M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about CorMedix's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude